We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Three patients had atypical carcinoids, one with multipleendocrineneoplasia type 1 syndrome.
2
Pituitary adenomas represent one of the key features of multipleendocrineneoplasia type 1.
3
She was diagnosed as having multipleendocrineneoplasia type 1 with gastrinoma and liver metastases.
4
At diagnosis, all patients were checked for the presence of multipleendocrineneoplasia type I syndrome.
5
One patient presented with multipleendocrineneoplasia syndrome.
6
The multipleendocrineneoplasia syndromes are an association of tumours of 2 or more endocrine glands.
7
Eight patients had sporadic NETs, and 1 had multipleendocrineneoplasia type 1 syndrome.
8
Medullary thyroid carcinoma is the most common cause of death among patients with multipleendocrineneoplasia (MEN) 2.
9
The diagnosis of medullary thyroid carcinoma by biochemical and genetic testing is possible in families with multipleendocrineneoplasia type 2.
10
Combined biochemical and genetic screening for multipleendocrineneoplasia type 2 is important and effective for the cure of medullary thyroid carcinoma.
11
All were symptomatic at presentation except one who had multiglandular involvement as a part of multipleendocrineneoplasia (MEN)-I screening.
12
Of the 43 pheochromocytomas, 16 were neoplasms inherited in the setting of multipleendocrineneoplasia type 2A.
13
Early diagnosis of multipleendocrineneoplasia (MEN) syndromes is critical for optimal clinical outcomes; before the MEN syndromes can be diagnosed, they must be suspected.
14
An association between blood type O and neuroendocrine tumors in multipleendocrineneoplasia type 1 (MEN1) patients was recently suggested.
15
Linkage between seven loci on chromosome 19 and multipleendocrineneoplasia type 2a (MEN2A) was examined in a single large Swedish pedigree.
16
Objective and design: Genetic screening in multipleendocrineneoplasia type 2 (MEN 2) has led to specific management guidelines based on genotype-phenotype analysis.